Skip to main content
Top
Published in: Inflammation 2/2012

01-04-2012

Ethanol Extract of Elaeocarpus petiolatus Inhibits Lipopolysaccharide-Induced Inflammation in Macrophage Cells

Authors: Ok-Kyoung Kwon, Kyung-Seop Ahn, Ji-Won Park, Ha-Young Jang, Hyouk Joung, Hyeong-Kyu Lee, Sei-Ryang Oh

Published in: Inflammation | Issue 2/2012

Login to get access

Abstract

Elaeocarpus petiolatus is known to exert active oxygen scavenging, anti-aging, and whitening actions. However, the biological effects of E. petiolatus on inflammation and the underlying mechanisms are yet to be established. In the present study, we investigated the anti-inflammatory effects of the ethanol extract from E. petiolatus (EPE) bark in murine Raw264.7 macrophages stimulated with lipopolysaccharide (LPS). EPE inhibited the production of PGE2, TNF-α, and IL-1β in a dose-dependent manner in Raw264.7 cells stimulated with LPS. The decrease in PGE2 production was correlated with reduced COX-2 expression. Furthermore, EPE suppressed the phosphorylation of extracellular signal-related kinases (ERK), c-Jun N-terminal kinase (JNK), and p38 as well as translocation of the NF-κB p65 subunit from the cytosol to nucleus. Our results suggest that EPE exerts anti-inflammatory activity through inhibition of inflammatory mediators, such as PGE2, TNF-α, and IL-1β, and downregulation of COX-2 via suppression of NF-κB translocation and phosphorylation of ERK, JNK, and p38 in LPS-stimulated Raw264.7 cells.
Literature
1.
go back to reference Wu, Z.Y., P.H. Raven, and D.Y. Hong. 2007. Flora of China. Beijing/St. Louis: Science Press/Missouri Botanical Garden Press. Wu, Z.Y., P.H. Raven, and D.Y. Hong. 2007. Flora of China. Beijing/St. Louis: Science Press/Missouri Botanical Garden Press.
2.
go back to reference Coode, M.J.E. 2001. Elaeocarpus in New Guinea—new taxa in the Debruynii subgroup of the Monocera group. Contributions to the Flora of Mt Jaya, V. Kew Bulletin, United Kingdom. Coode, M.J.E. 2001. Elaeocarpus in New Guinea—new taxa in the Debruynii subgroup of the Monocera group. Contributions to the Flora of Mt Jaya, V. Kew Bulletin, United Kingdom.
3.
go back to reference Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 13: 85–94.PubMedCrossRef Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 13: 85–94.PubMedCrossRef
4.
go back to reference Turini, M.E., and R.N. DuBois. 2002. Cyclooxygenase-2: a therapeutic target. Annual Reviews Medicine 53: 35–57.CrossRef Turini, M.E., and R.N. DuBois. 2002. Cyclooxygenase-2: a therapeutic target. Annual Reviews Medicine 53: 35–57.CrossRef
5.
go back to reference Rocca, B., and G.A. FitzGerald. 2002. Cyclooxygenases and prostaglandins: shaping up the immune response. International Immunopharmacology 2: 603–630.PubMedCrossRef Rocca, B., and G.A. FitzGerald. 2002. Cyclooxygenases and prostaglandins: shaping up the immune response. International Immunopharmacology 2: 603–630.PubMedCrossRef
6.
go back to reference Williams, J.A., and E. Shacter. 1997. Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. The Journal of Biological Chemistry 272: 25693–25699.PubMedCrossRef Williams, J.A., and E. Shacter. 1997. Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. The Journal of Biological Chemistry 272: 25693–25699.PubMedCrossRef
7.
go back to reference Vane, J.R. 1976. Prostaglandins as mediators of inflammation. Advances in Prostaglandin and Thromboxane Research 2: 791–801.PubMed Vane, J.R. 1976. Prostaglandins as mediators of inflammation. Advances in Prostaglandin and Thromboxane Research 2: 791–801.PubMed
8.
go back to reference Vane, J.R., J.A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D.A. Willoughby. 1994. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proceedings of the National Academy of Sciences of the United States of America 91: 2046–2050.PubMedCrossRef Vane, J.R., J.A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D.A. Willoughby. 1994. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proceedings of the National Academy of Sciences of the United States of America 91: 2046–2050.PubMedCrossRef
9.
go back to reference Johnson, G.L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911–1912.PubMedCrossRef Johnson, G.L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911–1912.PubMedCrossRef
10.
go back to reference Kim, Y.H., S.H. Lee, J.Y. Lee, S.W. Choi, J.W. Park, and T.K. Kwon. 2004. Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase. European Journal of Pharmacology 494: 1–9.PubMedCrossRef Kim, Y.H., S.H. Lee, J.Y. Lee, S.W. Choi, J.W. Park, and T.K. Kwon. 2004. Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase. European Journal of Pharmacology 494: 1–9.PubMedCrossRef
11.
go back to reference Olsson, S., and R. Sundler. 2006. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Molecular Immunology 43: 607–612.PubMedCrossRef Olsson, S., and R. Sundler. 2006. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Molecular Immunology 43: 607–612.PubMedCrossRef
13.
go back to reference Vanden Berghe, W., S. Plaisance, E. Boone, K. De Bosscher, M.L. Schmitz, W. Fiers, and G. Haegeman. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. The Journal of Biological Chemistry 273: 3285–3290.PubMedCrossRef Vanden Berghe, W., S. Plaisance, E. Boone, K. De Bosscher, M.L. Schmitz, W. Fiers, and G. Haegeman. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. The Journal of Biological Chemistry 273: 3285–3290.PubMedCrossRef
14.
go back to reference Genovese, M.C. 2005. Biologic therapies in clinical development for the treatment of rheumatoid arthritis. Journal of Clinical Rheumatology 11: S45–S54.PubMedCrossRef Genovese, M.C. 2005. Biologic therapies in clinical development for the treatment of rheumatoid arthritis. Journal of Clinical Rheumatology 11: S45–S54.PubMedCrossRef
15.
go back to reference Kobori, M., M. Yoshida, M. Ohnishi-Kameyama, and H. Shinmoto. 2007. Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells. British Journal of Pharmacology 150: 209–219.PubMedCrossRef Kobori, M., M. Yoshida, M. Ohnishi-Kameyama, and H. Shinmoto. 2007. Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells. British Journal of Pharmacology 150: 209–219.PubMedCrossRef
16.
go back to reference Qureshi, N., S.N. Vogel, C. Van Way 3rd, C.J. Papasian, A.A. Qureshi, and D.C. Morrison. 2005. The proteasome: a central regulator of inflammation and macrophage function. Immunologic Research 31: 243–260.PubMedCrossRef Qureshi, N., S.N. Vogel, C. Van Way 3rd, C.J. Papasian, A.A. Qureshi, and D.C. Morrison. 2005. The proteasome: a central regulator of inflammation and macrophage function. Immunologic Research 31: 243–260.PubMedCrossRef
17.
go back to reference Malyshev, I.Y., and A. Shnyra. 2003. Controlled modulation of inflammatory, stress and apoptotic responses in macrophages. Current Drug Targets. Immune, Endocrine and Metabolic Disorders 3: 1–22.PubMedCrossRef Malyshev, I.Y., and A. Shnyra. 2003. Controlled modulation of inflammatory, stress and apoptotic responses in macrophages. Current Drug Targets. Immune, Endocrine and Metabolic Disorders 3: 1–22.PubMedCrossRef
18.
go back to reference Jiang, Q., I. Elson-Schwab, C. Courtemanche, and B.N. Ames. 2000. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proceedings of the National Academy of Sciences of the United States of America 97: 11494–11499.PubMedCrossRef Jiang, Q., I. Elson-Schwab, C. Courtemanche, and B.N. Ames. 2000. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proceedings of the National Academy of Sciences of the United States of America 97: 11494–11499.PubMedCrossRef
19.
go back to reference Kwon, O.K., M.Y. Lee, J.E. Yuk, S.R. Oh, Y.W. Chin, H.K. Lee, and K.S. Ahn. Anti-inflammatory effects of methanol extracts of the root of Lilium lancifolium on LPS-stimulated Raw264.7 cells. Journal of Ethnopharmacology 130:28–34. Kwon, O.K., M.Y. Lee, J.E. Yuk, S.R. Oh, Y.W. Chin, H.K. Lee, and K.S. Ahn. Anti-inflammatory effects of methanol extracts of the root of Lilium lancifolium on LPS-stimulated Raw264.7 cells. Journal of Ethnopharmacology 130:28–34.
20.
go back to reference Lii, C.K., H.W. Chen, W.T. Yun, and K.L. Liu. 2009. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages. Journal of Ethnopharmacology 122: 227–233.PubMedCrossRef Lii, C.K., H.W. Chen, W.T. Yun, and K.L. Liu. 2009. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages. Journal of Ethnopharmacology 122: 227–233.PubMedCrossRef
21.
go back to reference Sheeba, M.S., and V.V. Asha. 2009. Cardiospermum halicacabum ethanol extract inhibits LPS induced COX-2, TNF-alpha and iNOS expression, which is mediated by NF-kappaB regulation, in RAW264.7 cells. Journal of Ethnopharmacology 124: 39–44.PubMedCrossRef Sheeba, M.S., and V.V. Asha. 2009. Cardiospermum halicacabum ethanol extract inhibits LPS induced COX-2, TNF-alpha and iNOS expression, which is mediated by NF-kappaB regulation, in RAW264.7 cells. Journal of Ethnopharmacology 124: 39–44.PubMedCrossRef
22.
go back to reference Mestre, J.R., K. Subbaramaiah, P.G. Sacks, S.P. Schantz, T. Tanabe, H. Inoue, and A.J. Dannenberg. 1997. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. Cancer Research 57: 1081–1085.PubMed Mestre, J.R., K. Subbaramaiah, P.G. Sacks, S.P. Schantz, T. Tanabe, H. Inoue, and A.J. Dannenberg. 1997. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. Cancer Research 57: 1081–1085.PubMed
23.
go back to reference Dean, J.L., M. Brook, A.R. Clark, and J. Saklatvala. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. The Journal of Biological Chemistry 274: 264–269.PubMedCrossRef Dean, J.L., M. Brook, A.R. Clark, and J. Saklatvala. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. The Journal of Biological Chemistry 274: 264–269.PubMedCrossRef
24.
go back to reference Xie, W., and H.R. Herschman. 1996. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. The Journal of Biological Chemistry 271: 31742–31748.PubMedCrossRef Xie, W., and H.R. Herschman. 1996. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. The Journal of Biological Chemistry 271: 31742–31748.PubMedCrossRef
25.
go back to reference Guan, Z., S.Y. Buckman, A.P. Pentland, D.J. Templeton, and A.R. Morrison. 1998. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway. The Journal of Biological Chemistry 273: 12901–12908.PubMedCrossRef Guan, Z., S.Y. Buckman, A.P. Pentland, D.J. Templeton, and A.R. Morrison. 1998. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway. The Journal of Biological Chemistry 273: 12901–12908.PubMedCrossRef
26.
go back to reference Rajapakse, N., M.M. Kim, E. Mendis, and S.K. Kim. 2008. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-kappaB signaling. Immunology 123: 348–357.PubMedCrossRef Rajapakse, N., M.M. Kim, E. Mendis, and S.K. Kim. 2008. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-kappaB signaling. Immunology 123: 348–357.PubMedCrossRef
27.
go back to reference Kretz-Remy, C., P. Mehlen, M.E. Mirault, and A.P. Arrigo. 1996. Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. The Journal of Cell Biology 133: 1083–1093.PubMedCrossRef Kretz-Remy, C., P. Mehlen, M.E. Mirault, and A.P. Arrigo. 1996. Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. The Journal of Cell Biology 133: 1083–1093.PubMedCrossRef
28.
go back to reference Palaniyar, N., J. Nadesalingam, and K.B. Reid. 2002. Pulmonary innate immune proteins and receptors that interact with gram-positive bacterial ligands. Immunobiology 205: 575–594.PubMedCrossRef Palaniyar, N., J. Nadesalingam, and K.B. Reid. 2002. Pulmonary innate immune proteins and receptors that interact with gram-positive bacterial ligands. Immunobiology 205: 575–594.PubMedCrossRef
29.
go back to reference Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115–122.PubMedCrossRef Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115–122.PubMedCrossRef
30.
go back to reference Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annual Review of Immunology 21: 335–376.PubMedCrossRef Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annual Review of Immunology 21: 335–376.PubMedCrossRef
31.
go back to reference Hayden, M.S., and S. Ghosh. 2004. Signaling to NF-kappa B. Genes & Development 18: 2195–2224. Hayden, M.S., and S. Ghosh. 2004. Signaling to NF-kappa B. Genes & Development 18: 2195–2224.
32.
go back to reference Huang, Q., J. Yang, Y. Lin, C. Walker, J. Cheng, Z.G. Liu, and B. Su. 2004. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nature Immunology 5: 98–103. Huang, Q., J. Yang, Y. Lin, C. Walker, J. Cheng, Z.G. Liu, and B. Su. 2004. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nature Immunology 5: 98–103.
Metadata
Title
Ethanol Extract of Elaeocarpus petiolatus Inhibits Lipopolysaccharide-Induced Inflammation in Macrophage Cells
Authors
Ok-Kyoung Kwon
Kyung-Seop Ahn
Ji-Won Park
Ha-Young Jang
Hyouk Joung
Hyeong-Kyu Lee
Sei-Ryang Oh
Publication date
01-04-2012
Publisher
Springer US
Published in
Inflammation / Issue 2/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9343-3

Other articles of this Issue 2/2012

Inflammation 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.